Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 19 mai 2023

    Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen.

    Pelletier B, Duhamel S, Tambutet G, Jarvis S, Cléroux P, David M, Tanguay PL, Voisin L, James C, Lavoie R, Gareau Y, Flynn-Robitaille J, Lorca T, Ruel R, Marinier A, Meloche S
    ACS Chem Biol 2023-05-19 ;18( 5 ):1039-1046

  • 9 mai 2023

    Towards clinically meaningful expansion of human HSCs.

    Tellechea MF, Chagraoui J, Cohen S, Sauvageau G
    Cell Res 2023-05-09 ;

  • 4 mai 2023

    K29-linked unanchored polyubiquitin chains disrupt ribosome biogenesis and direct ribosomal proteins to the Intranuclear Quality control compartment (INQ).

    Suresh HG, Bonneil E, Albert B, Dominique C, Costanzo M, Pons C, David Masinas MP, Shuteriqi E, Shore D, Henras AK, Thibault P, Boone C, Andrews BJ
    bioRxiv 2023-05-04 ;

  • 2 mai 2023

    Mnk1/2 kinases regulate memory and autism-related behaviours via Syngap1.

    Chalkiadaki K, Hooshmandi M, Lach G, Statoulla E, Simbriger K, Amorim IS, Kouloulia S, Zafeiri M, Pothos P, Bonneil E, Gantois I, Popic J, Kim SH, Wong C, Cao R, Komiyama NH, Atlasi Y, Jafarnejad SM, Khoutorsky A, Gkogkas CG
    Brain 2023-05-02 ;146( 5 ):2175-2190

  • 20 avril 2023

    The DynaSig-ML Python package: automated learning of biomolecular dynamics-function relationships.

    Mailhot O, Major F, Najmanovich R
    Bioinformatics 2023-04-20 ;

  • 8 avril 2023

    The Ubiquitination Status of the Glucagon Receptor determines Signal Bias.

    Kaur S, Sokrat B, Capozzi ME, El K, Bai Y, Jazic A, Han B, Krishnakumar K, D'Alessio DA, Campbell JE, Bouvier M, Shenoy SK
    J Biol Chem 2023-04-08 ;104690

  • 5 avril 2023

    Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer.

    Cameron S, Deblois G, Hawley JR, Qamra A, Zhou S, Tonekaboni SAM, Murison A, Van Vliet R, Liu J, Locasale JW, Lupien M
    Oncogene 2023-04-05 ;

  • 1er avril 2023

    Rewiring of catecholamine-induced calcium signalling is an early event in non-alcoholic fatty liver disease.

    Wright SC, Lauschke VM
    J Physiol 2023-04-01 ;601( 8 ):1317-1318

Voir plus de publications